US 12246023
Use of reboxetine to treat narcolepsy
granted A61KA61K31/5375A61P
Quick answer
US patent 12246023 (Use of reboxetine to treat narcolepsy) held by AXSOME THERAPEUTICS, INC. expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/5375, A61P, A61P25/02, A61P25/20